Clinical Trials
135 trialsGRECCAR12
University Hospital, Bordeaux
A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECTIL
University Hospital, Rouen
iRECOVER
University Hospital, Basel, Switzerland
RAPIDO
University Medical Center Groningen
Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer
Sun Yat-sen University
Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial
Shandong Cancer Hospital and Institute
CRITâ…¡
Sixth Affiliated Hospital, Sun Yat-sen University
ETAP
Institut Paoli-Calmettes
00-046
Memorial Sloan Kettering Cancer Center
FOBEAR
Sun Yat-sen University
Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer
Universitätsmedizin Mannheim
mEHT
Dalin Tzu Chi General Hospital
NORAD01
Assistance Publique - Hôpitaux de Paris
WW3
Vejle Hospital
GRECCAR8
Hospices Civils de Lyon
OPERA
Centre Antoine Lacassagne
REACT
Erasmus Medical Center
MTM-COLON-II
Centre Hospitalier Universitaire, Amiens
RIFIONA
Centre Hospitalier Universitaire, Amiens
FIDURA
Sahlgrenska University Hospital
Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study
Fudan University
OPLAR
West China Hospital
COPEC
West China Hospital
mRCAT-III
Sir Run Run Shaw Hospital
Néofirinox
UNICANCER
MRD-GI
Georgetown University
ENSEMBLE
National Cancer Center Hospital East
Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial
Peter MacCallum Cancer Centre, Australia
NeoCaCRT-III
Shenzhen People's Hospital
Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy
Kyung Hee University Hospital at Gangdong
Short RT Versus RCT,Followed by Chemo.and Organ Preservation for Interm and High-risk Rectal Cancer Patients
Goethe University
COLORII
Nova Scotia Health Authority
GRECCAR15
University Hospital, Bordeaux
ProMeLAR
Blokhin's Russian Cancer Research Center
TAUTEM-T1
Corporacion Parc Tauli
Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer
Memorial Sloan Kettering Cancer Center
ASCOLT
National Cancer Centre, Singapore
Total Neoadjuvant Treatment ±Immunotherapy for High Risk Locally Advanced Rectal Cancer (TNTi)
Peking University Cancer Hospital & Institute
Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer
St. James's Hospital, Ireland
NACRE
UNICANCER
BRAZIL-TNT
Hospital Israelita Albert Einstein
Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer
First Affiliated Hospital of Guangxi Medical University
CAIRO4
Dutch Colorectal Cancer Group
Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Sun Yat-sen University
TaLaR-02
Sun Yat-sen University
GRECCAR1
Institut du Cancer de Montpellier - Val d'Aurelle
CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients
Sun Yat-sen University
Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma
Sir Run Run Shaw Hospital